Recombinant poliovirus RNA polymerase expressed in E. coli demonstrates functional polymerase activity in vitro.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications; leaves open further mechanistic and antiviral studies of picornavirus polymerases.
A cDNA clone encoding the RNA polymerase of poliovirus has been expressed in Escherichia coli under the transcriptional control of a T7 bacteriophage promoter. The poliovirus enzyme was designed to contain only a single additional amino acid, the N-terminal methionine. The recombinant enzyme has been purified to near homogeneity, and polyclonal antibodies have been prepared against it. The enzyme exhibits poly(A)-dependent oligo(U)-primed poly(U) polymerase activity as well as RNA polymerase activity. In the presence of an oligo(U) primer, the enzyme catalyzes the synthesis of a full-length copy of either poliovirus or globin RNA templates. In the absence of added primer, RNA products up to twice the length of the template are synthesized. When incubated in the presence of a single nucleoside triphosphate, [alpha-32P]UTP, the enzyme catalyzes the incorporation of radioactive label into template RNA. These results are discussed in light of previously proposed models of poliovirus RNA synthesis in vitro.
No takes yet. Share an insight, caveat, or question.
Plotch et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: